In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Danaher Corp (Symbol: DHR) has taken over the #44 spot from Abbott Laboratories (Symbol: ABT), according to ETF Channel.  Below is a chart of Danaher Corp versus Abbo

Danaher Takes Over #44 Spot From Abbott Laboratories

(RTTNews) - Monday, Abbott Laboratories (ABT) announced one-year results for its investigational Amulet 360 Left Atrial Appendage Occluder from the VERITAS study, evaluating the safety and effectiveness of the device.

Abbott Laboratories Amulet 360 Achieves 98% Stroke-Free Rate In VERITAS Study 

Key PointsMedtronic recently completed a key spinoff of its diabetes segment.

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?

(RTTNews) - Wednesday, Tarsus Pharmaceuticals, Inc. (TARS) said it has appointed Neera Clase as Chief Commercial Officer (CCO), effective November 1, 2026.

Tarsus Names Neera Clase Commercial Chief To Expand XDEMVY Reach And Lead Pipeline Planning 

Key PointsAbbott Laboratories’ third-quarter results were somewhat mixed, with the company’s nutrition business still dragging down sales growth.

This Dividend King Just Announced Great News for Investors

Key PointsAbbott Laboratories maintains a highly diversified healthcare business spanning medical technology, diagnostics, and nutrition.

Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Abbott Laboratories News